French stocks experienced a downturn on Monday following a survey indicating that France's manufacturing sector contracted at its fastest rate since January, primarily due to a significant decline in output and new orders.
The HCOB France Manufacturing Purchasing Managers' Index (PMI), compiled by S&P Global, decreased to 43.9 in August from 44.0 in July.
Additionally, a separate survey highlighted that manufacturing activity in the Eurozone continued to be in a state of contraction throughout August.
The benchmark CAC 40 index dropped 23 points, or 0.30 percent, to 7,608, following a slight decline on Friday.
In corporate developments, Atos fell by 3.5 percent after the IT firm revised its annual revenue forecasts downward in response to the current business climate in its key markets.
Conversely, Sanofi gained nearly 2 percent. The pharmaceutical giant announced plans to commence discussions about filing its oral BTK inhibitor, tolebrutinib, for the treatment of multiple sclerosis.
